Ask sales for the Certificate of Analysis matched to the offered or supplied lot; it records the tests actually completed, applicable specifications, and reported results.
Review the matching batch COA for the analytical scope and results recorded for that lot.
Matching batch COA available.
FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Skin-radiance multi-peptide research blend
Overview
GLOW is a multi-peptide complex formulated as a synergistic blend studied in skin-health, radiance, and general-wellness research contexts. It is supplied as a single co-lyophilised cake so the released ratio between components is preserved rather than relying on a researcher to combine separate vials. Because GLOW is a defined proprietary blend rather than a single molecule, the released-batch COA characterises it by total peptide content (≥95.0%), peptide-profile mapping by LC-MS, molecular-weight distribution, water, endotoxin, heavy metals, residual solvents, and microbial limits. Exact component composition is held as proprietary; documented composition disclosure can be arranged under NDA for qualified B2B accounts.
Applications & buyer fit
Custom-blend buyers are almost always OEM clients building a branded product around a specific ratio of two or more peptides. The development workflow is collaborative: ratio target, analytical method to verify it, stability protocol in the chosen carrier, and packaging selection are all defined in the OEM brief before the first commercial run. Sample-stage volumes are usually 5-10 g of finished blend; commercial MOQ depends on the components.
Sourced for
Buyer fit
Documentation that ships
Procurement note: Ratio target, the analytical method to verify it, stability protocol, and packaging are defined in the OEM brief before the first commercial run.
Primary buyer fit: academic and contract research laboratories and regional distributors and re-sellers.
Specifications
Certificate of Analysis
Representative COA previews for GLOW Multi-Peptide Complex; request the certificate matched to the offered or supplied lot from sales. These are previews — request the full high-resolution certificate for any lot.
Browse all published COAsRegulatory note
Proprietary multi-peptide research blend; research-use-only, not for human or veterinary use. Composition is proprietary and disclosed under NDA to qualified accounts.
Frequently asked questions
GLOW is a proprietary multi-peptide complex formulated for skin-health and radiance research. The exact component peptides and their ratio are held as proprietary and are not printed on the public COA; documented composition can be shared under NDA with qualified B2B accounts. The released-batch COA verifies the blend by total peptide content (≥95.0%), peptide-profile mapping, and molecular-weight distribution so lot-to-lot consistency is documented.
Co-lyophilising the blend into one cake preserves the formulated ratio between components and avoids the surface-activity and mixing-error problems that come from reconstituting and combining multiple separate vials. The released-batch COA is issued against the finished complex, so the documentation matches exactly what is in the vial.
Related peptides